Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lack Of Year-End Conclusion To EU Trilogues Means More Timetable Shifts Likely

This article was originally published in Clinica

Executive Summary

All official meetings between the European Commission, the Council of the EU and the European Parliament to discuss the medical device and IVD regulatory texts have stopped ahead of the end of the Luxembourg Presidency of the Council. There is a hiatus now before these negotiations start up again under the Dutch Presidency in the new year. But where does that leave the medtech sector? Amanda Maxwell briefly summarizes the position as the year draws to a close

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel